Correlation Between Tenax Therapeutics and Capricor Therapeutics
Can any of the company-specific risk be diversified away by investing in both Tenax Therapeutics and Capricor Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tenax Therapeutics and Capricor Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tenax Therapeutics and Capricor Therapeutics, you can compare the effects of market volatilities on Tenax Therapeutics and Capricor Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tenax Therapeutics with a short position of Capricor Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tenax Therapeutics and Capricor Therapeutics.
Diversification Opportunities for Tenax Therapeutics and Capricor Therapeutics
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Tenax and Capricor is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Tenax Therapeutics and Capricor Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Capricor Therapeutics and Tenax Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tenax Therapeutics are associated (or correlated) with Capricor Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Capricor Therapeutics has no effect on the direction of Tenax Therapeutics i.e., Tenax Therapeutics and Capricor Therapeutics go up and down completely randomly.
Pair Corralation between Tenax Therapeutics and Capricor Therapeutics
Given the investment horizon of 90 days Tenax Therapeutics is expected to generate 2.0 times less return on investment than Capricor Therapeutics. In addition to that, Tenax Therapeutics is 2.62 times more volatile than Capricor Therapeutics. It trades about 0.02 of its total potential returns per unit of risk. Capricor Therapeutics is currently generating about 0.09 per unit of volatility. If you would invest 470.00 in Capricor Therapeutics on September 1, 2024 and sell it today you would earn a total of 1,431 from holding Capricor Therapeutics or generate 304.47% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tenax Therapeutics vs. Capricor Therapeutics
Performance |
| Timeline |
| Tenax Therapeutics |
| Capricor Therapeutics |
Tenax Therapeutics and Capricor Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tenax Therapeutics and Capricor Therapeutics
The main advantage of trading using opposite Tenax Therapeutics and Capricor Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tenax Therapeutics position performs unexpectedly, Capricor Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Capricor Therapeutics will offset losses from the drop in Capricor Therapeutics' long position.| Tenax Therapeutics vs. Allarity Therapeutics | Tenax Therapeutics vs. Neurobo Pharmaceuticals | Tenax Therapeutics vs. Virax Biolabs Group | Tenax Therapeutics vs. Quoin Pharmaceuticals Ltd |
| Capricor Therapeutics vs. Bio Path Holdings | Capricor Therapeutics vs. NextCure | Capricor Therapeutics vs. Pulmatrix | Capricor Therapeutics vs. Akari Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |